Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1100 of 2051 entries
View as:

Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)

Phase: N/A Priority: Normal
NCT ID: NCT03062358 Org: User:
Start: 04/27/17 End: 10/15/24 Due: 10/15/25

Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

Phase: N/A Priority: Normal
NCT ID: NCT00704184 Org: User:
Start: 07/25/08 End: 04/14/10 Due: 04/14/11

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00790556 Org: User:
Start: 10/31/08 End: 09/30/09 Due: 09/30/10

A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)

Phase: N/A Priority: Normal
NCT ID: NCT00746512 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)

Phase: N/A Priority: Normal
NCT ID: NCT00529659 Org: User:
Start: 10/31/07 End: 10/31/09 Due: 10/31/10

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)

Phase: N/A Priority: Normal
NCT ID: NCT03950622 Org: User:
Start: 06/13/19 End: 03/30/20 Due: 03/30/21

A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00418613 Org: User:
Start: 01/31/08 End: 03/31/09 Due: 03/31/10

Residual Curarization and Its Incidence at Tracheal Extubation (P08194)

Phase: N/A Priority: Normal
NCT ID: NCT01318382 Org: User:
Start: 06/30/11 End: 05/31/12 Due: 05/31/13

Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)

Phase: N/A Priority: Normal
NCT ID: NCT02252042 Org: User:
Start: 11/17/14 End: 08/15/22 Due: 08/15/23

An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

Phase: N/A Priority: Normal
NCT ID: NCT00511472 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)

Phase: N/A Priority: Normal
NCT ID: NCT00506987 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)

Phase: N/A Priority: Normal
NCT ID: NCT01078220 Org: User:
Start: 02/06/07 End: 12/13/10 Due: 12/13/11

A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)

Phase: N/A Priority: Normal
NCT ID: NCT01626794 Org: User:
Start: 07/31/14 End: 10/31/15 Due: 10/31/16

Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)

Phase: N/A Priority: Normal
NCT ID: NCT04633226 Org: User:
Start: 02/10/21 End: 11/04/22 Due: 11/04/23

A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)

Phase: N/A Priority: Normal
NCT ID: NCT06104449 Org: User:
Start: 11/14/23 End: 01/12/26 Due: 01/12/27

Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)

Phase: N/A Priority: Normal
NCT ID: NCT00988520 Org: User:
Start: 05/31/03 End: 09/30/03 Due: 09/30/04

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Phase: N/A Priority: Normal
NCT ID: NCT00092495 Org: User:
Start: 12/31/02 End: 02/28/09 Due: 02/28/10

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Phase: N/A Priority: Normal
NCT ID: NCT03010176 Org: User:
Start: 02/03/17 End: 04/21/22 Due: 04/21/23

A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00799708 Org: User:
Start: 05/31/08 End: 10/31/08 Due: 10/31/09

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Phase: N/A Priority: Normal
NCT ID: NCT00728494 Org: User:
Start: 10/31/05 End: 12/31/07 Due: 12/31/08

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00105157 Org: User:
Start: 03/31/05 End: 07/31/09 Due: 07/31/10

A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

Phase: N/A Priority: Normal
NCT ID: NCT02269735 Org: User:
Start: 11/26/14 End: 07/29/16 Due: 07/29/17

Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)

Phase: N/A Priority: Normal
NCT ID: NCT01963260 Org: User:
Start: 10/31/13 End: 04/26/15 Due: 04/26/16

The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)

Phase: N/A Priority: Normal
NCT ID: NCT00832624 Org: User:
Start: 11/26/08 End: 09/02/09 Due: 09/02/10

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

Phase: N/A Priority: Normal
NCT ID: NCT05093972 Org: User:
Start: 04/07/26 End: 09/10/26 Due: 09/10/27